Search for: "Ly v. Ins*"
Results 2181 - 2200
of 2,330
Sort by Relevance
|
Sort by Date
22 Jul 2008, 10:18 am
As ever it's the facts that make the case quite interesting, with the Defender trying to pick up and run with goodwill which, he was effectively saying, had been lying dormant. [read post]
19 Jul 2008, 7:23 am
Ohio when they decide Herring v. [read post]
19 Jul 2008, 2:09 am
Have a "CI's warning" akin to a Miranda warning that lying informants are prosecuted? [read post]
18 Jul 2008, 8:39 pm
In a case known as Mapp v. [read post]
16 Jul 2008, 6:59 am
It just may be, if David Kopel at VC is correct when he writes: District of Columbia v. [read post]
16 Jul 2008, 4:28 am
Ohio v. [read post]
13 Jul 2008, 3:36 pm
United States v. [read post]
10 Jul 2008, 4:16 am
" (Gregg v. [read post]
9 Jul 2008, 11:12 pm
Saffran v. [read post]
9 Jul 2008, 1:00 pm
” (R. v. [read post]
8 Jul 2008, 4:05 am
Livingston v. [read post]
25 Jun 2008, 3:54 pm
The Supreme Court of Missouri unanimously ruled en banc in State of Missouri v. [read post]
22 Jun 2008, 2:42 pm
United States v. [read post]
18 Jun 2008, 4:00 am
" blank">U.S. v. [read post]
9 Jun 2008, 9:39 pm
Bridge v. [read post]
5 Jun 2008, 10:12 pm
A few weeks ago the Court decided Carr-Gottstein Foods Co. v. [read post]
2 May 2008, 7:00 am
: Lupin v Abbott Labs: (FDA Law Blog), Plavix (Clopidogrel) – US: Apotex sues FDA to recover 180-day exclusivity on generic Plavix: (Orange Book Blog), Plavix (Clopidogrel) – US: Former Bristol-Myers Squibb executive charged over lying about Plavix deal struck with rival Apotex: (Managing Intellectual Property), Risperdal (Resperidone) – US: Apotex files motion to intervene in relisting of Risperdal patent case; Teva quickly files… [read post]
1 May 2008, 2:51 pm
United States v. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
20 Apr 2008, 8:01 am
That’s an issue that the Supreme Court agreed to review last week when it accepted cert in Goldstein v. [read post]
